Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAequs

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Trade Spotlight: How should you trade Bharat Dynamics, Cochin Shipyard, Max Financial Services, Alkem Labs, Bharti Airtel, and others on April 30?

      The benchmark indices need to decisively close above the previous day's high for a further upward move; until then, consolidation may be seen. Below are some short-term trading ideas to conside.

    • Trade Spotlight: How should you trade HUL, ITC, Titan, Tatva Chintan, Shriram Pistons, and others on Tuesday?

      The market is likely to consolidate, but the overall trend remains in favour of the bulls. Here are some trading ideas for the near term.

    • Trade Spotlight: How should you trade ITC, Dabur, Ipca Labs, Trent, Eclerx, Clean Science, and others on Friday?

      Experts suggest that unless Nifty 50 decisively climbs and sustains above 24,400—where the highest Call open interest is placed—the consolidation may continue, with support at the 24,000 mark. Here are some trading ideas for the near term.

    • Trade Spotlight: How should you trade Nestle, Alkem Labs, Hindustan Copper, BHEL, and others on Tuesday?

      The index is likely to trade within the 24,000-24,500 range. Breaking the upper range may take it towards 24,800, and below 24,000, the 23,700 level is the one to watch. Here are some trading ideas for the near term.

    • Hot Stocks | Expect healthy double-digit return in Alkem Laboratories, JK Lakshmi Cement, Torrent Pharma in short term

      The outlook for the Nifty Index leans towards a neutral scenario. There is an expectation of further rangebound movement in the Nifty, potentially between 18,830 – 19,560 levels.

    • Trade Spotlight: What should you do with Poonawalla Fincorp, HPCL, Alkem Laboratories today?

      Poonawalla Fincorp continued its healthy uptrend for yet another session, and formed robust bullish candlestick pattern on the daily charts, with strong volumes, after breaking out falling resistance trendline.

    • Hot Stocks | GMR Airports Infra, Alkem Laboratories, GSFC may fetch up to 21% in short term

      GMR Airports has maintained a level above Rs 34 consistently since early October 2021, indicating significant strength despite a market correction.

    • Trade Spotlight | What's your strategy for ICICI Bank, Trent, Alkem Laboratories today?

      Alkem Laboratories shares also rose 3 percent to Rs 3,396, the highest closing level since April 21 last year and formed long bullish candle on the daily scale with healthy volumes, continuing uptrend for fifth consecutive session.

    • Hot Stocks | Here'why Alkem Laboratories, Ajanta Pharma and L&T Infotech are short-term buys

      In the upcoming sessions, any sharp gains in the market may remain capped as long as Nifty trades below 15,900, said Shitij Gandhi of SMC Global Securities

    • Market off record high: Analysts pick these top 10 stocks for 16-53% returns

      Foreign money is clearly the key driver of the rally, along with improving macroeconomic data, better-than-expected September quarter earnings, and hopes that a COVID-19 vaccine is around the corner

    • Brokerages upgraded these 35 stocks in November; expect returns up to 40%

      The most noted point after September quarter earnings season was that more than 100 stocks witnessed upgrade in rating to buy from brokerages.

    • Market expected to remain volatile, analysts bet on these 10 stocks for healthy gains

      The surge in coronavirus infections, an acrimonious buildup to US elections and geopolitical reasons will keep volatility high that can act as a spoilsport, say experts.

    • As market valuations turn expensive, brokerages pick these 27 stocks

      In muted earnings expectations for Q1FY21, beats were much higher than misses and that was one of major reasons and confidence booster for equity market not only in India but globally.

    • Alkem Labs, Torrent Pharma expected to outperform, build long positions

      On the candlestick front, Alkem Labs has witnessed a 'Rising Three' formation on its daily scale which indicates the upmove to remain consistent & intact.

    • Infosys, Bharti Airtel, ICICI Bank among 26 stocks on analysts' radar post Q4 FY20

      The market's valuations have turned higher than long-period average and investors should be cautious and selective in picking stocks, say experts .

    • Building portfolio: Experts bet on 21 scrips to create wealth in coming years

      Aashish Somaiyaa of Motilal Oswal Asset Management Company advised that one should avoid panic and remain invested.

    • Brokerages recommend these 12 stocks in time of uncertainty; do you own any?

      Experts point out that the COVID-19 pandemic came in stages across the world and its fading away also will happen in phases over the next few quarters.

    • Nifty likely to trade in 8,000-9,000 range; 5 stocks for 1-3 months investment

      If VIX sustains above 50 levels, then pressure can be seen in the market. It needs to move below 40 levels for stability to return in the market.

    • Coronavirus pain may linger; 10 stocks you can consider for your portfolio

      Brokerages and analysts are of the view that the pain caused by COVID-19 may linger and the market is factoring in the hit on earnings and economic fallout from coronavirus outbreak.

    • Time to become greedy? Motilal Oswal suggests 10 stocks available at attractive valuations

      Motilal Oswal feels markets may continue to fall in near term, and that's the time to start becoming greedy. Hence the brokerage suggests accumulating on a gradual basis.

    • Sun Pharma, NCC and ACC among 10 stocks that could return 12-92% in long term

      The market is likely to remain in consolidation mode in next week amid corporate earnings, Delhi assembly elections results and domestic data including IIP, CPI and WPI.

    • Brokerages initiate coverage on these 10 stocks in July, expect 17-46% returns

      Despite the hangover induced by the Union Budget, various brokerages initiated coverage on these 10 stocks in July and projected 17-46 percent return in near to mid-term

    • Buy Alkem Laboratories, could give 21% return in one year: Ajcon Global

      We recommend buy with a target price of Rs 2,018, an upside of 21 percent for investors with a horizon of 12 months.

    • Small and mid-cap in ‘bear’ phase but these 5 stocks are looking attractive after fall

      As of now, mid-cap index is in “correction” and the small cap is in “rally attempt” till it breaches its recent lows

    • Buy Alkem Laboratories: Equity99

      At the CMP, the stock trades at a P/E of 34.6x. We are recommending a buy in staggered manner for medium to long term, says Sumit Bilgaiyan of Equity99.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347